Evidence map›Paper›PMID 29986638›Full record

ArticleTechnology in cancer research & treatment2018

Converting Treatment Plans From Helical Tomotherapy to L-Shape Linac: Clinical Workflow and Dosimetric Evaluation.

Zilong Yuan, Chithra Kumaran Nair, Stanley H Benedict, Richard K Valicenti, Shyam Rao, Ruben C Fragoso, Cari Wright, Jianfeng Qiu, Yi Rong

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Zilong Yuan1 Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA USA.ORCID 0000-0001-5856-6208
Chithra Kumaran Nair1 Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA USA.
Stanley H Benedict1 Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA USA.
Richard K Valicenti1 Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA USA.
Shyam Rao1 Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA USA.
Ruben C Fragoso1 Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA USA.
Cari Wright1 Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA USA.
Jianfeng Qiu3 Department of Radiology, Taishan Medical University, Tai'an, China.
Yi Rong1 Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA USA.
University of California Davis Medical Center · USTaishan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work evaluated a commercial fallback planning workflow designed to provide cross-platform treatment planning and delivery. A total of 27 helical tomotherapy intensity-modulated radiotherapy plans covering 4 anatomical sites were selected, including 7 brain, 5 unilateral head and neck, 5 bilateral head and neck, 5 pelvis, and 5 prostate cases. All helical tomotherapy plans were converted to 7-field/9-field intensity-modulated radiotherapy and volumetric-modulated radiotherapy plans through fallback dose-mimicking algorithm using a 6-MV beam model. The planning target volume (PTV) coverage ( D

Indexed as

BrainHumansMaleNeoplasmsOrgans at RiskProstateRadiometryRadiotherapy, ConformalRadiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedTomography, Spiral ComputedWorkflowfallback planninghelical tomotherapyhomogeneity indexintensity-modulated radiotherapyvolumetric-modulated radiotherapy

Identifiers

PMID29986638
PMCPMC6048611
OpenAlexW2871339976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.